Pancreatic well-differentiated neuroendocrine neoplasms (pWDNENs): what place for everolimus and sunitinib derived from ESMO clinical practice guidelines in the therapeutic algorithm?

Related Articles

Pancreatic well-differentiated neuroendocrine neoplasms (pWDNENs): what place for everolimus and sunitinib derived from ESMO clinical practice guidelines in the therapeutic algorithm?

Ann Oncol. 2013 Mar 13;

Authors: Pusceddu S, Buzzoni R, De Braud F

Abstract

PMID: 23493138 [PubMed - as supplied by publisher]

chir-258 dovitinib dna-pk